Closing Bell Recap: Regeneron Pharmaceuticals, Inc (REGN) Ends at 828.84, Reflecting a -1.75 Downturn

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) closed the day trading at $828.84 down -1.75% from the previous closing price of $843.60. In other words, the price has decreased by -$1.75 from its previous closing price. On the day, 0.74 million shares were traded. REGN stock price reached its highest trading level at $852.0 during the session, while it also had its lowest trading level at $826.76.

Ratios:

For a better understanding of REGN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.73. For the most recent quarter (mrq), Quick Ratio is recorded 4.46 and its Current Ratio is at 5.28. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on September 24, 2024, Downgraded its rating to Market Perform and sets its target price to $1077 from $1175 previously.

On March 12, 2024, Bernstein started tracking the stock assigning a Outperform rating and target price of $1125.

RBC Capital Mkts Upgraded its Sector Perform to Outperform on January 12, 2024, whereas the target price for the stock was revised from $884 to $1076.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 01 ’24 when MARION E MCCOURT bought 1,000 shares for $844.61 per share.

RYAN ARTHUR F sold 100 shares of REGN for $104,878 on Oct 01 ’24. The Director now owns 17,582 shares after completing the transaction at $1048.78 per share. On Oct 01 ’24, another insider, McCourt Marion, who serves as the EVP Commercial of the company, sold 1,000 shares for $1054.06 each. As a result, the insider received 1,054,060 and left with 12,931 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REGN now has a Market Capitalization of 92699123712 and an Enterprise Value of 82082004992. As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.51, and their Forward P/E ratio for the next fiscal year is 18.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.64 while its Price-to-Book (P/B) ratio in mrq is 3.11. Its current Enterprise Value per Revenue stands at 5.928 whereas that against EBITDA is 18.0.

Stock Price History:

Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $783.57. The 50-Day Moving Average of the stock is -21.16%, while the 200-Day Moving Average is calculated to be -18.16%.

Shares Statistics:

Over the past 3-months, REGN traded about 626.99K shares per day on average, while over the past 10 days, REGN traded about 949330 shares per day. A total of 107.60M shares are outstanding, with a floating share count of 106.30M. Insiders hold about 3.55% of the company’s shares, while institutions hold 86.69% stake in the company. Shares short for REGN as of 1728950400 were 1715921 with a Short Ratio of 2.74, compared to 1726185600 on 1976159. Therefore, it implies a Short% of Shares Outstanding of 1715921 and a Short% of Float of 1.6400000000000001.

Most Popular